COMMON STOCK PURCHASE WARRANT glyeco, inc.Common Stock Purchase Warrant • April 9th, 2018 • Wynnefield Partners Small Cap Value Lp I • Miscellaneous chemical products
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 6, 2018 (the “Issuance Date”) and on or prior to the close of business on the three (3)-year anniversary of the Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from GlyEco, Inc., a Nevada corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ContractWynnefield Partners Small Cap Value Lp I • April 9th, 2018 • Miscellaneous chemical products • New York
THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
SUBSCRIPTION AGREEMENTSubscription Agreement • January 6th, 2017 • Wynnefield Partners Small Cap Value Lp I • Miscellaneous chemical products • New York
This SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of the last date set forth on the signature page hereof between GlyEco, Inc., a Nevada corporation (the “Company”), and the undersigned (the “Subscriber”).
VOTING AGREEMENTVoting Agreement • June 27th, 2018 • Wynnefield Partners Small Cap Value Lp I • Broadwoven fabric mills, man made fiber & silk • Delaware
This VOTING AGREEMENT (the “Agreement”), dated as of June 24, 2018, is made by and among each of the Persons set forth on Schedule A hereto (individually, a “Stockholder” and, collectively, the “Stockholders”), and Andritz AG, a joint stock corporation organized under the laws of Austria with its seat at Graz, Austria (“Parent”). Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).
SETTLEMENT AGREEMENTSettlement Agreement • June 1st, 2020 • Wynnefield Partners Small Cap Value Lp I • Delaware
This Settlement Agreement (this “Agreement”), effective as of May 27, 2020 (the “Effective Date”), is entered into by and among MVC Capital, Inc., a Delaware corporation (the “Company”) and Wynnefield Partners Small Cap Value, L.P. I and the other persons and entities identified under that certain Wynnefield Schedule 13D (as defined below) as Reporting Persons (as defined therein) (each, a “Wynnefield Party” and collectively, the “Wynnefield Parties”). The Company and the Wynnefield Parties are collectively referred to herein as the “Parties,” and each of the Company and the collective Wynnefield Parties, a “Party.” Unless otherwise defined herein, capitalized terms shall have the meanings given to them in Section 15 herein.
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • August 11th, 2015 • Wynnefield Partners Small Cap Value Lp I • Fats & oils
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Omega Protein Corporation, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • July 20th, 2015 • Wynnefield Partners Small Cap Value Lp I • Services-educational services
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Learning Tree International, Inc., and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
XERIUM TECHNOLOGIES, INC. 14101 Capital Boulevard Youngsville, North Carolina 27596 CONFIDENTIALITY AND STANDSTILL AGREEMENTConfidentiality and Standstill Agreement • May 29th, 2018 • Wynnefield Partners Small Cap Value Lp I • Broadwoven fabric mills, man made fiber & silk • Delaware
In connection with our discussions with Wynnefield Capital Management, LLC, a New York limited liability company (“Wynnefield,” and, including all the signatories hereto, “you”), regarding Wynnefield’s investment in the securities of Xerium Technologies, Inc., a Delaware corporation (the “Company”), the Company may make available in its discretion certain information to you which is non-public, confidential and/or proprietary in nature.
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • June 12th, 2017 • Wynnefield Partners Small Cap Value Lp I • Pharmaceutical preparations
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Nature’s Sunshine Products, Inc., and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
SCHEDULE 13D JOINT FILING AGREEMENT13d Joint Filing Agreement • November 14th, 2012 • Wynnefield Partners Small Cap Value Lp I • Knit outerwear mills
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Hampshire Group, Limited is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
on board nominations FOR JULY 15th ANNUAL MeetingReach Agreement • June 1st, 2020 • Wynnefield Partners Small Cap Value Lp I
Purchase, N.Y., May 27, 2020 – MVC Capital, Inc. (NYSE: MVC) (the “Company” or “MVC”) and Wynnefield Capital (“Wynnefield”) today announced an agreement (the “Agreement”) under which six of MVC’s current directors and three independent director candidates proposed by Wynnefield will be nominated by MVC’s Board for election at the Company’s 2020 Annual Meeting of Stockholders, currently scheduled for July 15, 2020 (“the “Annual Meeting”).
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • June 1st, 2016 • Wynnefield Partners Small Cap Value Lp I
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of MVC Capital, Inc., and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • May 3rd, 2017 • Wynnefield Partners Small Cap Value Lp I • Broadwoven fabric mills, man made fiber & silk
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Xerium Technologies, Inc., and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • March 22nd, 2022 • Wynnefield Partners Small Cap Value Lp I • Miscellaneous manufacturing industries • Delaware
This VOTING AND SUPPORT AGREEMENT (this “Agreement”) is entered into as of March 16, 2022, by and between the undersigned stockholder (“Stockholder”) of Summer Infant, Inc., a Delaware corporation (the “Company”), and Kids2, Inc., a Georgia corporation (the “Parent”).
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • July 1st, 2015 • Wynnefield Partners Small Cap Value Lp I • Pharmaceutical preparations
The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of MusclePharm Corp., and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
